Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02030808Phase 2Completed
Phase 2, randomised, single-blind trial of remifentanil in thoracotomy (2 arms), sponsored by Imam Abdulrahman Bin Faisal University. Primary endpoint: Modified surgical rating scale at 3 hours. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02030808.